Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Individualized Pharmacological Approach to Obesity in Patients With Bipolar Disorder - OBOE-Mayo

NCT07213466 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.

NCT NCT07213466
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07213466 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Individualized Pharmacological Approach to Obesity in Patients With Bipolar Disorder - OBOE-Mayo
Lead sponsor
Mayo Clinic
Phase
Phase 4
Overall status
Recruiting
Start date
January 19, 2026
Completion date
February 1, 2029
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bipolar i disorder, bipolar ii disorder, glp - 1, obesity, schizo affective disorder, weight loss